Inovalon Holdings Inc (NASDAQ:INOV) has received an average rating of “Hold” from the six ratings firms that are covering the stock, MarketBeat Ratings reports. Five investment analysts have rated the stock with a hold rating and one has given a buy rating to the company. The average 12 month price target among analysts that have issued ratings on the stock in the last year is $15.33.

Several analysts recently weighed in on INOV shares. BidaskClub upgraded Inovalon from a “hold” rating to a “buy” rating in a report on Wednesday, February 20th. SunTrust Banks started coverage on Inovalon in a report on Friday, February 15th. They issued a “buy” rating and a $22.00 price objective for the company. Zacks Investment Research upgraded Inovalon from a “hold” rating to a “buy” rating and set a $16.00 price objective for the company in a report on Friday, January 4th. Morgan Stanley upgraded Inovalon from an “underweight” rating to an “equal weight” rating and lifted their price objective for the company from $10.00 to $13.00 in a report on Thursday, December 20th. Finally, ValuEngine downgraded Inovalon from a “buy” rating to a “hold” rating in a report on Thursday, March 7th.

Institutional investors have recently added to or reduced their stakes in the business. State Board of Administration of Florida Retirement System lifted its position in shares of Inovalon by 9.8% during the 4th quarter. State Board of Administration of Florida Retirement System now owns 23,109 shares of the technology company’s stock valued at $328,000 after buying an additional 2,064 shares in the last quarter. Legal & General Group Plc grew its holdings in shares of Inovalon by 19.9% during the 4th quarter. Legal & General Group Plc now owns 13,021 shares of the technology company’s stock worth $185,000 after purchasing an additional 2,163 shares during the period. California State Teachers Retirement System grew its holdings in shares of Inovalon by 0.4% during the 4th quarter. California State Teachers Retirement System now owns 676,995 shares of the technology company’s stock worth $8,389,000 after purchasing an additional 2,557 shares during the period. We Are One Seven LLC purchased a new position in Inovalon during the 4th quarter valued at about $40,000. Finally, Citigroup Inc. boosted its holdings in Inovalon by 13.4% during the 4th quarter. Citigroup Inc. now owns 27,054 shares of the technology company’s stock valued at $384,000 after acquiring an additional 3,193 shares during the period. Institutional investors and hedge funds own 33.55% of the company’s stock.

INOV stock opened at $11.87 on Thursday. The company has a quick ratio of 1.93, a current ratio of 1.93 and a debt-to-equity ratio of 1.40. The stock has a market capitalization of $1.83 billion, a P/E ratio of 65.94, a PEG ratio of 2.59 and a beta of 0.67. Inovalon has a 1-year low of $8.90 and a 1-year high of $15.57.

Inovalon (NASDAQ:INOV) last released its quarterly earnings data on Wednesday, February 20th. The technology company reported $0.05 earnings per share for the quarter, missing the consensus estimate of $0.07 by ($0.02). The firm had revenue of $136.30 million during the quarter, compared to the consensus estimate of $145.20 million. Inovalon had a negative net margin of 7.32% and a positive return on equity of 3.88%. The business’s revenue was up 18.9% compared to the same quarter last year. During the same quarter in the previous year, the firm earned $0.06 earnings per share. On average, sell-side analysts anticipate that Inovalon will post 0.33 EPS for the current fiscal year.

Inovalon Company Profile

Inovalon Holdings, Inc, a technology company, provides cloud-based platforms empowering a data-driven transformation from volume-based to value-based models in the healthcare industry. The company's platform enables the assessment and enhancement of clinical and quality outcomes and financial performance.

See Also: What is a closed-end mutual fund (CEF)?

Receive News & Ratings for Inovalon Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Inovalon and related companies with MarketBeat.com's FREE daily email newsletter.